Reirradiation based on diffusion-weighted magnetic resonance imaging-guided dose- painting for locally advanced recurrent nasopharyngeal carcinoma: a phase 2 randomized controlled trial.

Autores: Tan C; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.; Hunan Key Laboratory of Translational Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Hunan Cancer Hospital, Central South University, Changsha, Hunan, China., Li Y; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.; Hunan Key Laboratory of Translational Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Hunan Cancer Hospital, Central South University, Changsha, Hunan, China., Chen X; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China., Zhu W; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China., Jiang C; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., He L; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Xiao S; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Fan C; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Ye X; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Zhao Q; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Wu W; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Li Y; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Qiu Y; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Chen K; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Hu S; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China., Liu F; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China. liufeng820111@163.com.; Hunan Key Laboratory of Translational Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Hunan Cancer Hospital, Central South University, Changsha, Hunan, China. liufeng820111@163.com., Wang H; Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China. wanghui@hnca.org.cn.; Hunan Key Laboratory of Translational Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Hunan Cancer Hospital, Central South University, Changsha, Hunan, China. wanghui@hnca.org.cn.

Fonte: BMC cancer [BMC Cancer] 2025 Apr 07; Vol. 25 (1), pp. 622. Date of Electronic Publication: 2025 Apr 07.

Tipo de Publicación: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Nasopharyngeal Carcinoma*/radiotherapy , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Carcinoma*/mortality , Nasopharyngeal Carcinoma*/diagnostic imaging , Diffusion Magnetic Resonance Imaging*/methods , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects , Neoplasm Recurrence, Local*/radiotherapy , Neoplasm Recurrence, Local*/pathology , Neoplasm Recurrence, Local*/diagnostic imaging , Nasopharyngeal Neoplasms*/radiotherapy , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/mortality , Nasopharyngeal Neoplasms*/diagnostic imaging , Re-Irradiation*/methods , Re-Irradiation*/adverse effects , Radiotherapy, Image-Guided*/methods, Humans ; Female ; Male ; Middle Aged ; Adult ; Prospective Studies ; Aged ; Radiotherapy Dosage

Nasopharyngeal necrosis following intensity-modulated radiation therapy of primary nasopharyngeal carcinoma-incidence rate and predictors of risk.

Autores: Yang XL; Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510060, China., Lin L; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510080, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, 510080, China., He SS; Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510060, China., Wen DW; Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510060, China., Kou J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, 510080, China.; Department of Anesthesiology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510080, China., Wang Y; Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510060, China., Wang XC; Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510060, China. wangxc8@mail.sysu.edu.cn., Chen Y; Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510060, China. chenyong@mail.sysu.edu.cn.

Fonte: BMC cancer [BMC Cancer] 2025 Apr 29; Vol. 25 (1), pp. 802. Date of Electronic Publication: 2025 Apr 29.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Radiotherapy, Intensity-Modulated*/adverse effects , Nasopharyngeal Carcinoma*/radiotherapy , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Neoplasms*/radiotherapy , Nasopharyngeal Neoplasms*/pathology , Nasopharynx*/pathology , Nasopharynx*/radiation effects , Radiation Injuries*/epidemiology , Radiation Injuries*/etiology , Radiation Injuries*/pathology, Humans ; Middle Aged ; Male ; Female ; Necrosis/epidemiology ; Necrosis/etiology ; Retrospective Studies ; Adult ; Aged ; Incidence ; Risk Factors ; Radiotherapy Dosage ; Young Adult ; Adolescent ; Magnetic Resonance Imaging ; Aged, 80 and over

Intensity-modulated proton therapy for hippocampal-sparing prophylactic cranial irradiation: a planning comparison with photon therapy.

Autores: Yin X; Department of Radiation Oncology and Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, China., Lin X; Department of Radiation Physics, Shandong Second Provincial General Hospital, Jinan, China., Zhang G; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China., Yin Y; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China., Sun T; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China. freeww82@163.com.

Fonte: BMC cancer [BMC Cancer] 2025 Apr 08; Vol. 25 (1), pp. 639. Date of Electronic Publication: 2025 Apr 08.

Tipo de Publicación: Journal Article; Comparative Study

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Proton Therapy*/methods , Hippocampus*/radiation effects , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy Planning, Computer-Assisted*/methods , Cranial Irradiation*/methods , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Small Cell Lung Carcinoma*/radiotherapy , Small Cell Lung Carcinoma*/pathology , Brain Neoplasms*/prevention & control, Humans ; Male ; Radiotherapy Dosage ; Female ; Middle Aged ; Photons/therapeutic use ; Organ Sparing Treatments/methods ; Aged ; Organs at Risk/radiation effects ; Adult

A comparative study of different parameter estimation methods for predictive models of Normal Tissue Complication Probability (NTCP) of radiation-induced temporal lobe injury following intensity-modulated radiotherapy in nasopharyngeal carcinoma.

Autores: OuYang H; College of Vocational Teachers, Jiangxi Agricultural University, Nanchang, Jiangxi Province, 330045, P.R. China., Liu Y; College of Chemistry and Material, Jiangxi Agricultural University, Nanchang, Jiangxi Province, 330045, P.R. China., He X; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China., Zhang J; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China., Tao L; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China., Liu M; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China., Ding J; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China., Hu R; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China., Hu J; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China., Huang Z; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China., Deng S; The Rehabilitation College of Nanchang University, Nanchang, Jiangxi Province, 330031, P.R. China., Wu J; The Rehabilitation College of Nanchang University, Nanchang, Jiangxi Province, 330031, P.R. China., Xu Z; College of Computer Science, Sichuan University, Chengdu, Sichuan Province, 610065, P.R. China. jyh@qq.com., Luo Q; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China. luoqiwei@email.ncu.edu.cn., Zeng L; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, P.R. China. ndefy19019@ncu.edu.cn.

Fonte: BMC cancer [BMC Cancer] 2025 Mar 29; Vol. 25 (1), pp. 572. Date of Electronic Publication: 2025 Mar 29.

Tipo de Publicación: Journal Article; Comparative Study

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Nasopharyngeal Carcinoma*/radiotherapy , Radiotherapy, Intensity-Modulated*/adverse effects , Radiation Injuries*/etiology , Radiation Injuries*/diagnosis , Nasopharyngeal Neoplasms*/radiotherapy , Temporal Lobe*/radiation effects , Temporal Lobe*/injuries , Temporal Lobe*/pathology, Humans ; Male ; Female ; Middle Aged ; Adult ; Bayes Theorem ; Aged ; Probability ; Models, Statistical ; Young Adult

Segmentation methods and dosimetric evaluation of 3D-printed immobilization devices in head and neck radiotherapy.

Autores: Yin Y; College of Nuclear Technology and Automation Engineering, Chengdu University of Technology, Chengdu, 610059, China.; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China., Zhang W; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China., Zou L; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China., Liu X; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China., Yu L; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610072, China. yuluxin@med.uestc.edu.cn., Wang M; College of Nuclear Technology and Automation Engineering, Chengdu University of Technology, Chengdu, 610059, China. wangming1@cdut.edu.cn.

Fonte: BMC cancer [BMC Cancer] 2025 Feb 18; Vol. 25 (1), pp. 289. Date of Electronic Publication: 2025 Feb 18.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Printing, Three-Dimensional* , Head and Neck Neoplasms*/radiotherapy , Head and Neck Neoplasms*/diagnostic imaging , Radiotherapy Planning, Computer-Assisted*/methods , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/instrumentation , Immobilization*/instrumentation , Immobilization*/methods, Humans ; Radiotherapy Dosage ; Tomography, X-Ray Computed ; Deep Learning ; Radiometry

Comparative analysis of VMAT plans on Halcyon and infinity for lung cancer radiotherapy.

Autores: Shao K; Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, HangZhou, Zhejiang, China., Du F; Department of Radiation Physics, Zhejiang Cancer Hospital, HangZhou, Zhejiang, China., Qiu L; Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, HangZhou, Zhejiang, China., Zhang Y; Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, HangZhou, Zhejiang, China., Li Y; Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, HangZhou, Zhejiang, China., Ding J; Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, HangZhou, Zhejiang, China., Zhan W; Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, HangZhou, Zhejiang, China., Chen W; Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, HangZhou, Zhejiang, China.

Fonte: PloS one [PLoS One] 2025 Feb 11; Vol. 20 (2), pp. e0318462. Date of Electronic Publication: 2025 Feb 11 (Print Publication: 2025).

Tipo de Publicación: Journal Article; Comparative Study

Información da Revista: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Termos MeSH: Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/instrumentation , Radiotherapy Planning, Computer-Assisted*/methods , Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology, Humans ; Retrospective Studies ; Female ; Male ; Middle Aged ; Aged ; Radiotherapy Dosage ; Organs at Risk/radiation effects ; Particle Accelerators

Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers.

Autores: Ma J; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China., Xu X; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China., Huang W; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China., Hu Y; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China., Chen G; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China., He J; Department of Radiation Oncology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. hejian62@163.com.

Fonte: BMC cancer [BMC Cancer] 2025 Jan 22; Vol. 25 (1), pp. 118. Date of Electronic Publication: 2025 Jan 22.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Lung Neoplasms*/radiotherapy , Lung Neoplasms*/mortality , Lung Neoplasms*/pathology , Radiosurgery*/methods , Radiosurgery*/adverse effects , Neoplasms, Second Primary*/radiotherapy , Neoplasms, Second Primary*/mortality , Neoplasms, Second Primary*/pathology , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects, Humans ; Female ; Male ; Aged ; Middle Aged ; Prognosis ; Aged, 80 and over ; Retrospective Studies ; Neoplasm Recurrence, Local/epidemiology ; Kaplan-Meier Estimate ; Adult

The prognostic value of boost dose in residual cervical lymph nodes in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy: a retrospective study.

Autores: Xu M; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuma Road, Fuzhou, 350014, Fujian, People's Republic of China., Wang L; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuma Road, Fuzhou, 350014, Fujian, People's Republic of China., Ding J; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuma Road, Fuzhou, 350014, Fujian, People's Republic of China., Xu Y; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuma Road, Fuzhou, 350014, Fujian, People's Republic of China., Fei Z; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuma Road, Fuzhou, 350014, Fujian, People's Republic of China. feizhaodong@fjmu.edu.cn.

Fonte: BMC cancer [BMC Cancer] 2025 Feb 07; Vol. 25 (1), pp. 222. Date of Electronic Publication: 2025 Feb 07.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Radiotherapy, Intensity-Modulated*/methods , Nasopharyngeal Carcinoma*/radiotherapy , Nasopharyngeal Carcinoma*/mortality , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Carcinoma*/virology , Nasopharyngeal Neoplasms*/radiotherapy , Nasopharyngeal Neoplasms*/mortality , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/virology , Lymph Nodes*/pathology , Lymph Nodes*/radiation effects, Humans ; Female ; Male ; Retrospective Studies ; Middle Aged ; Prognosis ; Adult ; Aged ; Herpesvirus 4, Human/isolation & purification ; Herpesvirus 4, Human/genetics ; Radiotherapy Dosage ; Young Adult ; Epstein-Barr Virus Infections/virology ; Lymphatic Metastasis/radiotherapy ; Neck ; Adolescent

Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.

Autores: Jin J; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China., Guo SS; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China., Liu LT; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China., Wen DX; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China., Liu RP; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China., Lin JY; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China., Liu SQ; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China., Sun XS; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China., Liang YJ; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, Guangzhou, 510060, P. R. China., Tang LQ; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China. tanglq@sysucc.org.cn., Mai HQ; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China. maihq@sysucc.org.cn., Chen QY; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat-sen University Cancer Centre, 651 Dongfeng Road East, Guangzhou, 510060, P. R. China. chenqy@sysucc.org.cn.

Fonte: BMC cancer [BMC Cancer] 2024 Oct 02; Vol. 24 (1), pp. 1223. Date of Electronic Publication: 2024 Oct 02.

Tipo de Publicación: Journal Article; Comparative Study

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Quality of Life* , Nasopharyngeal Carcinoma*/radiotherapy , Nasopharyngeal Carcinoma*/psychology , Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy, Intensity-Modulated*/methods , Cancer Survivors*/psychology , Cancer Survivors*/statistics & numerical data , Nasopharyngeal Neoplasms*/radiotherapy , Nasopharyngeal Neoplasms*/psychology, Humans ; Male ; Female ; Adult ; Child ; Adolescent ; Middle Aged ; Young Adult ; Aged ; Health Status

Dosimetric effects of prone immobilization devices on skin in intensity-modulated radiation therapy for gynecologic cancer: a retrospective study.

Autores: Wang D; Department of Radiation Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Li B; Department of Plastic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China., Chen L; Department of Radiation Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Li Z; Department of Radiation Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Kong F; Department of Radiation Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Yan H; Department of Radiation Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Xu X; Department of Radiation Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Dong J; Department of Radiation Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. dongj23@mail.sysu.edu.cn.

Fonte: BMC cancer [BMC Cancer] 2024 Nov 28; Vol. 24 (1), pp. 1464. Date of Electronic Publication: 2024 Nov 28.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Radiotherapy, Intensity-Modulated*/methods , Radiotherapy Dosage* , Genital Neoplasms, Female*/radiotherapy , Radiotherapy Planning, Computer-Assisted*/methods , Skin*/radiation effects , Immobilization*/instrumentation , Immobilization*/methods, Humans ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Adult ; Organs at Risk/radiation effects ; Radiometry ; Phantoms, Imaging

Dose delivery uncertainties assessment in the field junction region of craniospinal irradiation with Volumetric Modulated Arc Therapy using a robustness index and experimental dose verification.

Autores: Peppa V; Medical Physics Laboratory, Medical School, National and Kapodistrian University of Athens, Athens, Greece.; Department of Radiotherapy, Alexandra Hospital, Athens, Greece., Zoros E; Medical Physics Laboratory, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Alexiou A; Department of Radiotherapy, Alexandra Hospital, Athens, Greece., Pissakas G; Department of Radiotherapy, Alexandra Hospital, Athens, Greece., Karaiskos P; Medical Physics Laboratory, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Fonte: PloS one [PLoS One] 2024 Nov 07; Vol. 19 (11), pp. e0313260. Date of Electronic Publication: 2024 Nov 07 (Print Publication: 2024).

Tipo de Publicación: Journal Article

Información da Revista: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Termos MeSH: Craniospinal Irradiation*/methods , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy Dosage* , Radiotherapy Planning, Computer-Assisted*/methods, Humans ; Retrospective Studies ; Uncertainty ; Phantoms, Imaging ; Male ; Child ; Female

Effect of breathing phase number on the 4D robust optimization for pancreatic cancer intensity modulated proton therapy.

Autores: Fan X; Department of Graduate, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China., Wang S; Department of Graduate, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China., Li W; Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China., Li T; Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China., Yin Y; Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China. yinyongsd@126.com., Dai T; Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China. daitianyuan1992@163.com.

Fonte: BMC cancer [BMC Cancer] 2024 Oct 30; Vol. 24 (1), pp. 1337. Date of Electronic Publication: 2024 Oct 30.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Pancreatic Neoplasms*/radiotherapy , Proton Therapy*/methods , Radiotherapy Planning, Computer-Assisted*/methods , Radiotherapy, Intensity-Modulated*/methods , Respiration* , Four-Dimensional Computed Tomography*/methods , Radiotherapy Dosage*, Humans ; Retrospective Studies ; Male ; Female ; Organs at Risk/radiation effects

A dosimetric and robustness analysis of proton arc therapy with early energy layer and spot assignment for lung cancer versus conventional intensity modulated proton therapy.

Autores: Chocan MS; Université catholique de Louvain, Institut de recherche expérimentale et clinique, Molecular Imaging and Radiation Oncology (MIRO) Laboratory, Brussels, Belgium. macarena.chocan@uclouvain.be., Wuyckens S; Université catholique de Louvain, Institut de recherche expérimentale et clinique, Molecular Imaging and Radiation Oncology (MIRO) Laboratory, Brussels, Belgium., Dasnoy D; Université catholique de Louvain, Institute of Information and Communication Technologies (ICTEAM), Louvain-La-Neuve, Belgium., Di Perri D; Department of Radiation Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Borderias Villarruel E; Université catholique de Louvain, Institut de recherche expérimentale et clinique, Molecular Imaging and Radiation Oncology (MIRO) Laboratory, Brussels, Belgium., Engwall E; RaySearch Laboratories - Research and Development Department, Stockholm, Sweden., Lee JA; Université catholique de Louvain, Institut de recherche expérimentale et clinique, Molecular Imaging and Radiation Oncology (MIRO) Laboratory, Brussels, Belgium., Barragan-Montero AM; Université catholique de Louvain, Institut de recherche expérimentale et clinique, Molecular Imaging and Radiation Oncology (MIRO) Laboratory, Brussels, Belgium., Sterpin E; Université catholique de Louvain, Institut de recherche expérimentale et clinique, Molecular Imaging and Radiation Oncology (MIRO) Laboratory, Brussels, Belgium; KULeuven, Department of Oncology, Laboratory of external radiotherapy, Leuven, Belgium; Particle Therapy Interuniversity Center Leuven - PARTICLE, Leuven, Belgium.

Fonte: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Oct 29; Vol. 63, pp. 805-815. Date of Electronic Publication: 2024 Oct 29.

Tipo de Publicación: Journal Article; Comparative Study

Información da Revista: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

Termos MeSH: Proton Therapy*/methods , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Radiotherapy Planning, Computer-Assisted*/methods , Radiotherapy, Intensity-Modulated*/methods , Organs at Risk*/radiation effects , Radiotherapy Dosage*, Humans ; Retrospective Studies ; Algorithms ; Radiometry/methods

Intensity-modulated proton radiotherapy spares musculoskeletal structures in regional nodal irradiation for breast cancer: a dosimetric comparison.

Autores: Burlile JF; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA. burlile.jessica@mayo.edu., Shiraishi S; Mayo Clinic Department of Medical Physics, Rochester, MN, USA., Gunn HJ; Mayo Clinic Department of Quantitative Health Sciences, Rochester, MN, USA., Bradt JL; Mayo Clinic Department of Rehabilitation, Rochester, MN, USA., Kroeplin HM; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Lang KG; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Cimmiyotti JK; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Depauw N; Massachusetts General Hospital Department of Radiation Oncology, Boston, MA, USA., Chang CY; Massachusetts General Hospital Department of Radiology, Boston, MA, USA., Brom KM; Mayo Clinic Department of Medical Physics, Rochester, MN, USA., Sonnicksen CL; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA., Vu A; Mayo Clinic Alix School of Medicine, Rochester, MN, USA., Jimenez RB; Massachusetts General Hospital Department of Radiation Oncology, Rochester, MN, USA., Corbin KS; Mayo Clinic Department of Radiation Oncology, Rochester, MN, USA.

Fonte: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Oct 01; Vol. 63, pp. 755-762. Date of Electronic Publication: 2024 Oct 01.

Tipo de Publicación: Journal Article; Comparative Study

Información da Revista: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

Termos MeSH: Radiotherapy, Intensity-Modulated*/methods , Breast Neoplasms*/radiotherapy , Breast Neoplasms*/pathology , Proton Therapy*/methods , Radiotherapy Planning, Computer-Assisted*/methods , Organs at Risk*/radiation effects , Radiotherapy Dosage*, Humans ; Female ; Lymphatic Irradiation/methods ; Musculoskeletal System/radiation effects ; Shoulder/radiation effects ; Middle Aged

Is clinical target volume necessary for locally advanced non-small cell lung cancer treated with 4D-CT intensity-modulated radiation therapy.

Autores: Ding W; Department of Oncology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, China.; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Ji Shou University, Jishou, China., Xu T; Department of Oncology, The Second Xiangya Hospital of Central South University, Central South University, Changsha, China., Xiang H; Department of Oncology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, China.; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Ji Shou University, Jishou, China., Liang J; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Ji Shou University, Jishou, China., Liang W; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Ji Shou University, Jishou, China., Xiang N; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Ji Shou University, Jishou, China., Zhao J; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Ji Shou University, Jishou, China., Li G; Department of Oncology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, China. ligy@zknu.edu.cn.; Key Laboratory of Modern Teaching Technology, Ministry of Education, Shaanxi Normal University, Xi'an, Shaanxi, China. ligy@zknu.edu.cn.; College of Life Science and Agronomy, Zhoukou Normal University, Zhoukou, Henan, China. ligy@zknu.edu.cn.; Academy of medical science, Zhengzhou University, Zhengzhou, Henan, China. ligy@zknu.edu.cn., Song Z; Department of Oncology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, China. xy3songzw@csu.edu.cn.; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Ji Shou University, Jishou, China. xy3songzw@csu.edu.cn.

Fonte: BMC cancer [BMC Cancer] 2024 Sep 27; Vol. 24 (1), pp. 1198. Date of Electronic Publication: 2024 Sep 27.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Carcinoma, Non-Small-Cell Lung*/radiotherapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Radiotherapy, Intensity-Modulated*/methods , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Lung Neoplasms*/diagnostic imaging , Radiotherapy Planning, Computer-Assisted*/methods , Radiotherapy Dosage* , Four-Dimensional Computed Tomography*/methods , Organs at Risk*/radiation effects, Humans ; Female ; Male ; Aged ; Middle Aged ; Retrospective Studies ; Neoplasm Staging ; Adult ; Aged, 80 and over ; Tumor Burden

Clinical significance of intensity-modulated radiotherapy (IMRT) to the distant metastatic lymph nodes for metastatic cervical cancer.

Autores: Fang C; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China., Liu S; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China., Xia J; Department of Digestive Endoscopic Center, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China., Wu X; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. wu.xh@fudan.edu.cn., Zhu J; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. dragonzld@163.com., Ke G; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China. kegh5734@126.com.

Fonte: BMC cancer [BMC Cancer] 2024 Sep 20; Vol. 24 (1), pp. 1170. Date of Electronic Publication: 2024 Sep 20.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Uterine Cervical Neoplasms*/radiotherapy , Uterine Cervical Neoplasms*/pathology , Uterine Cervical Neoplasms*/mortality , Radiotherapy, Intensity-Modulated*/methods , Lymphatic Metastasis*/radiotherapy , Lymph Nodes*/pathology, Humans ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; Neoplasm Staging ; Clinical Relevance

Utilizing radiomics and dosiomics with AI for precision prediction of radiation dermatitis in breast cancer patients.

Autores: Lee TF; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC.; Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan, ROC.; Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan, ROC., Chang CH; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC., Chi CH; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC., Liu YH; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC., Shao JC; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC., Hsieh YW; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC., Yang PY; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC., Tseng CD; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC., Chiu CL; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC., Hu YC; Department of Radiation Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC., Lin YW; Department of Radiation Oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC., Chao PJ; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC. pjchao99@gmail.com., Lee SH; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC. tflee@nkust.edu.tw.; Department of Radiation Oncology, Linkou Chang Gung Memorial Hospitaland, Chang Gung University College of Medicine, Linkou, Taiwan, ROC. tflee@nkust.edu.tw., Yeh SA; Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung University of Science and Technology, Jiangong RdSanmin Dist., No.415, Kaohsiung, 80778, Taiwan, ROC. sayeh@outlook.com.; Department of Medical Imaging and Radiological Sciences, I-Shou University, Kaohsiung, 82445, Taiwan, ROC. sayeh@outlook.com.; Department of Radiation Oncology, E-DA Hospital, Kaohsiung, 82445, Taiwan, ROC. sayeh@outlook.com.

Fonte: BMC cancer [BMC Cancer] 2024 Aug 06; Vol. 24 (1), pp. 965. Date of Electronic Publication: 2024 Aug 06.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Breast Neoplasms*/radiotherapy , Breast Neoplasms*/diagnostic imaging , Radiodermatitis*/etiology , Radiodermatitis*/diagnostic imaging , Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy, Intensity-Modulated*/methods, Humans ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Adult ; Radiotherapy Planning, Computer-Assisted/methods ; Tomography, X-Ray Computed/methods ; Radiotherapy Dosage ; Artificial Intelligence ; Radiomics

Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial.

Autores: Wang L; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China., Liu L; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China., Cao Y; Anti-Cancer Association of Hebei Province, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Chen X; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China., Liu S; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China., Li X; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China., Han J; Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China., Wang Q; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China., Han C; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China. 46100725@hebmu.edu.cn.

Fonte: BMC cancer [BMC Cancer] 2024 Jun 04; Vol. 24 (1), pp. 679. Date of Electronic Publication: 2024 Jun 04.

Tipo de Publicación: Journal Article; Clinical Trial, Phase II

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Esophageal Squamous Cell Carcinoma*/therapy , Esophageal Squamous Cell Carcinoma*/radiotherapy , Esophageal Squamous Cell Carcinoma*/pathology , Esophageal Squamous Cell Carcinoma*/mortality , Radiotherapy, Intensity-Modulated*/methods , Radiotherapy, Intensity-Modulated*/adverse effects , Esophageal Neoplasms*/radiotherapy , Esophageal Neoplasms*/pathology , Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/mortality , Esophageal Neoplasms*/drug therapy , Chemoradiotherapy*/methods, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Agents, Immunological/administration & dosage ; Treatment Outcome

Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.

Autores: Zhou J; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China., Wang L; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China., Qiu T; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China., Gao H; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China., Wang L; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China., Huang S; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China., He X; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China. hexiabm@163.com., Wu L; Department of Radiation Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China. wulirong126@126.com.

Fonte: BMC cancer [BMC Cancer] 2024 May 27; Vol. 24 (1), pp. 648. Date of Electronic Publication: 2024 May 27.

Tipo de Publicación: Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Deglutition Disorders*/etiology , Xerostomia*/etiology , Nasopharyngeal Carcinoma*/radiotherapy , Nasopharyngeal Carcinoma*/complications , Nasopharyngeal Carcinoma*/pathology , Radiotherapy, Intensity-Modulated*/adverse effects , Radiotherapy, Intensity-Modulated*/methods , Nasopharyngeal Neoplasms*/radiotherapy , Nasopharyngeal Neoplasms*/complications, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Follow-Up Studies ; Adult ; Aged ; Radiation Injuries/etiology ; Radiation Injuries/prevention & control ; Deglutition ; Salivary Glands/radiation effects ; Salivary Glands/pathology ; Salivary Glands/diagnostic imaging ; Radiotherapy Dosage ; Prognosis ; Young Adult

NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial.

Autores: Fan Z; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Li D; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Yan S; Department of Urology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China., Zhao X; Department of Radiation Oncology, The First Affiliated Hospital of Naval Medical Uiversity, 168 Changhai Road, Shanghai, 200433, China.; Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215000, China., Yin L; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Xu W; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Wang Y; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Zhang H; Department of Radiation Oncology, The First Affiliated Hospital of Naval Medical Uiversity, 168 Changhai Road, Shanghai, 200433, China. huojunzh@163.com., Chang Y; Department of Urology, The First Affiliated Hospital of Naval Medical Uiversity, 168 Changhai Road, Shanghai, 200433, China. 13661652533@163.com., Ren S; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China. renshancheng@gmail.com.

Fonte: BMC cancer [BMC Cancer] 2025 Apr 24; Vol. 25 (1), pp. 768. Date of Electronic Publication: 2025 Apr 24.

Tipo de Publicación: Clinical Trial Protocol; Journal Article

Información da Revista: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Termos MeSH: Neoadjuvant Therapy*/methods , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/therapy , Prostatic Neoplasms*/mortality, Aged ; Humans ; Male ; Androstenes/administration & dosage ; Androstenes/therapeutic use ; Gonadotropin-Releasing Hormone/therapeutic use ; Gonadotropin-Releasing Hormone/administration & dosage ; Multicenter Studies as Topic ; Neoplasm Metastasis ; Prospective Studies ; Prostatectomy/methods ; Radiotherapy, Intensity-Modulated/methods ; Randomized Controlled Trials as Topic ; Standard of Care